A nomogram for predicting survival in advanced non-small cell lung carcinoma patients: a population-based study.
Bo YangMengmeng TengHaisheng YouYalin DongSiying ChenPublished in: Cancer investigation (2023)
Non-small cell lung cancer remains the most common malignant cancer. We identified 43140 advanced NSCLC patients from the SEER database to develop and validate a new prognostic model. The prognostic performance was evaluated by P value, concordance index, net reclassification index, integrated discrimination improvement, and decision curve analysis. The following variables were contained in the final prognostic model: age, sex, race, TNM stage, and grade and treatment options. Compared to the AJCC staging system, this prognostic model is conducive to the implementation of individualized clinical treatment schemes and can be an important part in the precise medical care of NSCLC tumors.
Keyphrases
- end stage renal disease
- ejection fraction
- small cell lung cancer
- newly diagnosed
- chronic kidney disease
- primary care
- healthcare
- emergency department
- prognostic factors
- stem cells
- lymph node
- advanced non small cell lung cancer
- young adults
- bone marrow
- pet ct
- patient reported
- replacement therapy
- epidermal growth factor receptor
- adverse drug